Status:
RECRUITING
Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells
Lead Sponsor:
IRCCS San Raffaele
Collaborating Sponsors:
Università Vita-Salute San Raffaele
Conditions:
Carcinoma, Renal Cell
Von Hippel-Lindau Disease
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to analyze somatic mutations in the genome of normal kidney cells from patients affected by kidney cancer predisposition syndrome Von Hippel Lindau (VHL) and co...
Eligibility Criteria
Inclusion
- Genetic diagnosis of VHL-disease; age (data need to be collected from a population distributed between 25 and 65 years); gender (males and females should be equally represented);
Exclusion
- patients with bilateral nephrectomy, in dialysis or kidney transplant; use of nephrotoxic drugs
Key Trial Info
Start Date :
June 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06194669
Start Date
June 30 2023
End Date
December 31 2027
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Ospedale San Raffaele
Milan, Italy, 20132